Acadia Healthcare Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Acadia Healthcare Inc's ROI in the first quarter of 2026?
Acadia Healthcare Company Inc had a negative return on investment (ROI) of -20.18%, due to the net loss of $-1 billion, during the twelve months ending in the first quarter of 2026.

Within the Healthcare sector 331 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 2516 to 3252.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Investment Change TTM	1.37 %	7.43 %	14.22 %	15.56 %	14.62 %
Y / Y Net Income Change TTM	-	-	-48.54 %	-4.82 %	147.27 %
Investment (TTM) in Millions	5,057	5,002	5,895	5,785	5,674
Return On Investment (TTM)	-20.18 %	-19.54 %	2.09 %	2.75 %	3.63 %
ACHC's Overall Ranking	# 3252	# 2516	# 1638	# 1490	# 1119
Seq. Investment Change TTM	-2.76 %	-1.66 %	2.87 %	3.05 %	3.06 %
Seq. Net Income Change TTM	-	-	-21.76 %	-22.02 %	-26.36 %
Net Income (TTM) in Millions	-1,097	-1,092	119	152	195

ACHC Company Profile >> Back to ACHC Roi Comparisons >> See Annual ACHC Return On Investment

Return On Investment ACHC's Ranking
Within:	No.
Industry	# 34
Sector	# 332
Overall	# 3252

Return On Investment Statistics
High	Average	Low
6.34 %	0.48 %	-19.78 %
(Jun 30 2022)		(Mar 31 2026)

Financial Statements
Acadia Healthcare Inc's I. Quarter Investments	$ 5,057 Millions	ACHC's Balance sheet
Acadia Healthcare Inc's I. Quarter Income	$ 4 Millions	Quarterly ACHC's Income Statement
ACHC's Income by Division		See ACHC's Income by Division

ACHC Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	5,002	5,379	4,473	4,600	4,363
Y / Y Investment Growth	-7 %	20.25 %	-2.75 %	5.42 %	-15.95 %
Net Income in Millions	-1,092	264	-16	280	196
Y / Y Net Income Growth	-	-	-	43.19 %	-
Annual Return On Investment	-21.83 %	4.92 %	-0.35 %	6.09 %	4.48 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ACHC's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ACHC's Competitors
Subscribers only: Roi for Acadia Healthcare Inc's Suppliers
Subscribers only: Return On Investment for ACHC's Customers

Other Ratios
ACHC's Roa	ACHC's Inventory Turnover Ratio	ACHC's Growth Rates	ACHC's Dividend Statistics
	ACHC's Profitability Ratios	ACHC's Asset Turnover Ratio	ACHC's Dividend Growth
ACHC's Roe	ACHC's Valuation Ratios	ACHC's Financial Strength Ratios	ACHC's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector

ROI

Date modified: 2026-09-18T13:11:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.